EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prospects of engineered bacteria-assisted CAR T Cell therapy in gastrointestinal cancers

Qingqing Zhang, Xiao Song, Junhong Liu, Xuejiao Zhou

Oncology Reviews · 14.04.2025 · 19

DOI: 10.3389/or.2025.1581856 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Reviews, online erschienen am 14.04.2025. Verfasst von Qingqing Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine, Weifang People's Hospital, Weifang, Shandong, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The high incidence and mortality rates associated with gastrointestinal cancers represent a significant global health challenge. In recent years, CAR T cell therapy has emerged as a promising immunotherapeutic approach, demonstrating favorable clinical outcomes. However, the application of traditional CAR T cell therapy in gastrointestinal cancers faces numerous challenges, including the suppressive tumor microenvironment and limitations in anti-tumor efficacy. The application of engineered bacteria offers a novel strategy to enhance CAR T cell therapy by modulating the tumor microenvironment and boosting immune responses, potentially leading to improved therapeutic outcomes. This review synthesizes the current research advancements related to engineered bacteria-assisted CAR T cell therapy in gastrointestinal cancers, exploring its underlying mechanisms, clinical applications, and future developmental directions.

Schlagwörter

Stichwörter der Autor:innen

CAR T cell therapyengineered bacteriagastrointestinal cancersimmunotherapytumor microenvironment

Autor:innen und Institutionen

  • Reproductive Medicine, Weifang People's Hospital, Weifang, Shandong, China.
  • Department of Gastroenterology, Weifang People's Hospital, Weifang, Shandong, China.
  • The Third Department of Geriatrics, Weifang People's Hospital, Weifang, Shandong, China.
  • Hospital Preparation Center, Weifang People's Hospital, Weifang, Shandong, China.

Zitieren

APA

Zhang, Q., Song, X., Liu, J., & Zhou, X. (2025). Prospects of engineered bacteria-assisted CAR T Cell therapy in gastrointestinal cancers. Oncology Reviews, 19. https://doi.org/10.3389/or.2025.1581856

Vancouver

Zhang Q, Song X, Liu J, Zhou X. Prospects of engineered bacteria-assisted CAR T Cell therapy in gastrointestinal cancers. Oncology Reviews. 2025;19. doi:10.3389/or.2025.1581856

BibTeX
@article{Zhang2025,
  author = {Zhang, Qingqing and Song, Xiao and Liu, Junhong and Zhou, Xuejiao},
  title = {Prospects of engineered bacteria-assisted CAR T Cell therapy in gastrointestinal cancers},
  journal = {Oncology Reviews},
  year = {2025},
  volume = {19},
  doi = {10.3389/or.2025.1581856}
}
Kostenlos starten →